• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quince Therapeutics, Inc. - Common Stock (NQ:QNCX)

0.6100 +0.0823 (+15.60%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 841,538,300
Open 0.7151
Bid (Size) 0.5300 (100)
Ask (Size) 0.5400 (3,000)
Prev. Close 0.5277
Today's Range 0.5251 - 0.9801
52wk Range 0.1251 - 4.550
Shares Outstanding 36,382,989
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Micro-Caps Under $1: TOON, PRSO, RENX, QNCX, KIDZ Building Momentum
Today 16:39 EST
Via AB Newswire
Topics Economy Intellectual Property
Curious about the most active stocks on Wednesday? ↗
Today 14:00 EST
Via Chartmill

Performance

YTD
-79.7%
-79.7%
1 Month
-79.3%
-79.3%
3 Month
-65.9%
-65.9%
6 Month
-66.7%
-66.7%
1 Year
-57.3%
-57.3%

More News

Read More
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
Today 13:00 EST
Via Chartmill
Top stock movements in today's session. ↗
Today 12:30 EST
Via Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Today 8:30 EST
Via Chartmill
These stocks are making the most noise in today's session. ↗
February 10, 2026
Via Chartmill
These stocks are gapping in today's session ↗
February 10, 2026
Via Chartmill
Top movers in Tuesday's pre-market session ↗
February 10, 2026
Via Chartmill
News headline image
Why Is QNCX Stock Up 60% Pre-Market After A Near-Total Wipeout? ↗
February 10, 2026
Via Stocktwits
News headline image
Why Is Quince Therapeutics Stock Soaring Tuesday? ↗
February 10, 2026
Via Benzinga
Monday's after hours session: top gainers and losers ↗
February 09, 2026
Via Chartmill
News headline image
Quince Therapeutics Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Alternatives
February 09, 2026
From Quince Therapeutics, Inc.
Via Business Wire
The trading volume of these stocks is deviating from the norm in today's session. ↗
February 02, 2026
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
January 30, 2026
Via Chartmill
Top movers analysis in the middle of the day on 2026-01-30: top gainers and losers in today's session. ↗
January 30, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
January 30, 2026
Via Chartmill
News headline image
Why Did QNCX Stock Plummet Over 90% Today? ↗
January 29, 2026
Via Stocktwits
Topics Bankruptcy
News headline image
Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia
January 29, 2026
From Quince Therapeutics, Inc.
Via Business Wire
News headline image
Quince Therapeutics Presents Safety Data from Long-Term eDSP Treatment in Children with Ataxia-Telangiectasia at British Paediatric Neurology Association Annual Meeting
January 28, 2026
From Quince Therapeutics, Inc.
Via Business Wire
News headline image
Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia
December 15, 2025
From Quince Therapeutics, Inc.
Via Business Wire
News headline image
Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders
December 10, 2025
From Quince Therapeutics, Inc.
Via Business Wire
News headline image
Wednesday's session: top gainers and losers ↗
November 26, 2025
Via Chartmill
News headline image
Which stocks are moving on Wednesday? ↗
November 26, 2025
Via Chartmill
News headline image
Quince Therapeutics to Participate at Investor Events in December 2025
November 24, 2025
From Quince Therapeutics, Inc.
Via Business Wire
News headline image
Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
November 12, 2025
From Quince Therapeutics, Inc.
Via Business Wire

Frequently Asked Questions

Is Quince Therapeutics, Inc. - Common Stock publicly traded?
Yes, Quince Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Quince Therapeutics, Inc. - Common Stock trade on?
Quince Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Quince Therapeutics, Inc. - Common Stock?
The ticker symbol for Quince Therapeutics, Inc. - Common Stock is QNCX on the Nasdaq Stock Market
What is the current price of Quince Therapeutics, Inc. - Common Stock?
The current price of Quince Therapeutics, Inc. - Common Stock is 0.6100
When was Quince Therapeutics, Inc. - Common Stock last traded?
The last trade of Quince Therapeutics, Inc. - Common Stock was at 02/11/26 04:00 PM ET
What is the market capitalization of Quince Therapeutics, Inc. - Common Stock?
The market capitalization of Quince Therapeutics, Inc. - Common Stock is 22.19M
How many shares of Quince Therapeutics, Inc. - Common Stock are outstanding?
Quince Therapeutics, Inc. - Common Stock has 22M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap